GHR-LRX

Drug identity checked against registry records

Also recorded as ISIS 766720

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With AcromegalyNCT04522180IONSPhase 2Completed2022-07-15Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.